Keywords: merck, kgaa, concor, shows, good, efficacy, novel

Merck KGaA's Concor shows good efficacy with novel ACE regimen

Article | 12 September 2005

Print This

l Darmstadt, Germany-based drugmaker Merck KGaA says that results of a 1,010-patient clinical trial in chronic heart failure showed that ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in